Ikarian Capital »

Centessa Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.5M 308k 24.25
2025-06-30 $2.6M 200k 13.14

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
General Atlantic
FMR
Henderson Group
Farallon Capital Management
First Light Asset Management
Siren
TCG Crossover Management
Perceptive Advisors
Commodore Capital
Franklin Resources
Rtw Investments
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals